TokenPost topic

Yorvipath

1 TokenPost story is tagged Yorvipath. The newest appear first.

Latest Yorvipath stories

• Ascendis Pharma Reports Strong Phase 3 Durability Data for Yorvipath

  Ascendis Pharma reported long-term Phase 3 data showing Yorvipath sustained biochemical control and reduced supplement reliance in hypoparathyroidism patients over 3.5 years.

  Jun 15, 2026, 12:26 AM EDT · Business